Navigation Links
New Chief Executive Officer and Vice President Commercial Operations USA at the Helsinn Group's American subsidiary, Helsinn Therapeutics (U.S.) Inc.
Date:9/9/2009

the Group subsidiaries, or eventually out-licensed to its network of local marketing and commercial partners, selected for their deep in-market knowledge and know-how, and assisted and supported with a full range of product and scientific management services, including commercial, regulatory, financial, legal and medical marketing advice.

The active pharmaceutical ingredients and the finished dosage forms are manufactured at Helsinn's cGMP facilities in Switzerland and Ireland, and supplied worldwide to its customers. Helsinn is the worldwide licensor of palonosetron, a second generation 5-HT3 receptor antagonist, for the prevention of chemotherapy-induced nausea and vomiting (CINV) and of post-operative nausea and vomiting (PONV) in patients with cancer, and of the original nimesulide, a non-steroidal anti-inflammatory drug (NSAID) distributed in more than 50 countries worldwide.

Helsinn, with a workforce of around 450 employees in Switzerland, Ireland and USA, reported a 2008 turnover of over CHF 280.3 million (about EUR 178 million), covering 75 countries worldwide, with over 20% of this turnover invested in R&D.

For more information about Helsinn Group, please visit the website: http://www.helsinn.com

    Contact person at Helsinn Healthcare SA:
    Paola Bonvicini
    Head of Communication & Press Office
    Tel.: +41-91-985-21-21
    E-Mail: info-hhc@helsinn.com

'/>"/>
SOURCE Helsinn Healthcare SA
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. ResMed Names Kieran Gallahue as Chief Executive Officer, Effective January 1, 2008.
2. WorldHeart Appoints David Pellone Chief Financial Officer
3. Mediware Names Thomas K. Mann Chief Executive Officer
4. Dr. Allen Woolf Appointed Chief Medical Officer For CIGNA Group Insurance
5. Sean P. McLaughlin Joins Red Cross as Chief of Operations Support
6. VNUS Medical Technologies Announces Resignation of Chief Financial Officer and VP, Finance & Administration
7. Coalition America Announces Addition of Mollie Gordon Brown as Chief Strategy Officer
8. STERIS Corporation Board of Directors Names Walter M. Rosebrough Jr. President and Chief Executive Officer
9. Karen Vigil Named Senior Vice President and Chief Executive Officer, Blue Shield of Californias Individual, Small Group, and Government Business Unit
10. Response Biomedical appoints S. Wayne Kay Chief Executive Officer
11. Psychemedics Corporation Joins Accenture in Co-Sponsoring Innovative Chief Talent Officer Book
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2009)... 15 Senetek PLC (OTC Bulletin Board: SNKTY), a Life Sciences company engaged in ... announced that shareholders had approved all three resolutions that the Company had proposed at the ... , , Description of ... Votes Non-, ... For ...
(Date:12/15/2009)... 15 Our Lady of Lourdes Health Care ... hospitals, has agreed to pay the United States $7.95 ... the Justice Department announced today. The two hospitals are ... N.J., and Lourdes Medical Center of Burlington County (LMC) ... in a suit brought by a whistleblower, Tony Kite, ...
(Date:12/15/2009)... 800,000 doses have lower strength than needed for protection, ... Almost 800,000 children,s doses of H1N1 swine flu vaccine ... they have lost some potency, federal health officials said ... Control and Prevention, the company,s routine testing of the ... years found that four batches had lower than required ...
(Date:12/15/2009)... Pa., Dec. 15 4R Systems, Inc., ... chain solutions which help retailers significantly increase profits ... decisions, announced today that The Vitamin Shoppe has ... ,, "4R,s store and DC inventory solutions have ... efficiency and in-stocks over the last two years," ...
(Date:12/15/2009)... BRAINTREE, Mass., Dec. 15 North American ... +3.9% in November year-over-year, according to the ... life insurance applications over the past three months ... 2009 levels of -1.6%, to flat at November,s ... recovering their interest in the benefits available from ...
Breaking Medicine News(10 mins):Health News:Senetek PLC Announces 2009 Annual General Meeting Voting Results 2Health News:Senetek PLC Announces 2009 Annual General Meeting Voting Results 3Health News:Parent Company of Two New Jersey Hospitals to Pay U.S. $7.95 Million to Settle False Claims Act Allegations 2Health News:Large Recall of Children's Swine Flu Vaccine 2Health News:4R's Profit Optimizing Inventory Solutions Helps The Vitamin Shoppe Drive Increased Productivity and Performance 2Health News:4R's Profit Optimizing Inventory Solutions Helps The Vitamin Shoppe Drive Increased Productivity and Performance 3Health News:4R's Profit Optimizing Inventory Solutions Helps The Vitamin Shoppe Drive Increased Productivity and Performance 4Health News:MIB Life Index Reports North American Life Insurance Activity Up 3.9% in November 2Health News:MIB Life Index Reports North American Life Insurance Activity Up 3.9% in November 3
... Clinics Struggle to Bridge GapsSAN FRANCISCO, Jan. 15 ... California show that the shortage among allied health workers ... organizations. This shortage is causing a number of problems ... clinic,s ability to serve more patients."Community clinics represent the ...
... 15 As today,s aging population spends increasing ... for mood-enhancing foods will continue to experience healthy ... worldwide consulting and research firm Kline & ... industry has so far focused mainly on physical ...
... increasingly turning to home care vs. assisted livingGLEN ELLYN, ... has affected all aspects of life, and long term ... sell their homes, moving to an assisted living facility ... option of aging-in-place with retrofits is growing in popularity ...
... in spite of their universal health care system which ... the United Kingdom are less willing to undergo dementia ... Britons perceive greater societal stigma from diagnosis of the ... older adults in Indianapolis and 120 older adults in ...
... Deceptive Advertising ClaimsNEW YORK, Jan. 15 A class ... States District Court for the Northern District of California ... deceptive advertising in marketing its VitaminWater line of beverages. ... Kallas, LLC ("WDK"), Reese Richman LLP, and the Center ...
... Company announced today it has agreed to plead guilty ... billion in criminal and civil fines, penalties and damages ... the pharmaceutical giant defrauded Medicare, Medicaid and other government-funded ... for its blockbuster atypical antipsychotic, Zyprexa. The settlement ...
Other Medicine News:Health News:Allied Health Worker Shortage Strains Community Clinics 2Health News:Allied Health Worker Shortage Strains Community Clinics 3Health News:Mood-Enhancing and Heart Health Foods Emerging as Incidence of Heart Diseases Rises 2Health News:Mood-Enhancing and Heart Health Foods Emerging as Incidence of Heart Diseases Rises 3Health News:Housing Crisis Affects Seniors Needing Care 2Health News:Housing Crisis Affects Seniors Needing Care 3Health News:Does universal health care affect attitude toward dementia? 2Health News:Coca-Cola Sued Over Deceptive VitaminWater Claims 2Health News:Eli Lilly Pays a Record $1.4 Billion to Settle Federal and State Fraud Investigations into Illegal Zyprexa Off-Label Marketing Practices 2Health News:Eli Lilly Pays a Record $1.4 Billion to Settle Federal and State Fraud Investigations into Illegal Zyprexa Off-Label Marketing Practices 3Health News:Eli Lilly Pays a Record $1.4 Billion to Settle Federal and State Fraud Investigations into Illegal Zyprexa Off-Label Marketing Practices 4
(Date:12/15/2009)... BALTIMORE, Dec. 15 Champions Biotechnology, ... engaged in the development of advanced preclinical platforms ... of oncology drugs, today announced its financial results ... 2009. Full details of Company,s financial results ... www.championsbiotechnology.com . ,, Total revenues for the ...
(Date:12/15/2009)... -- The U.S. Food and Drug Administration (FDA) Endocrinologic ... yes, 4 no, and 1 abstention that AstraZeneca has ... support the use of CRESTOR® (rosuvastatin calcium) in individuals ... or equal to 50 years, women greater than or ... 130 mg/dL; hsCRP greater than or equal to 2.0 ...
(Date:12/15/2009)... 15 Dakim, Inc. and Alzheimer,s Weekly today ... Ones, Brain Health Contest, designed to help five seniors ... and Alzheimer,s disease. All five winners will receive a ... to help seniors preserve their brain health and the ... living communities across the country. ,, The ...
Breaking Medicine Technology:Champions Biotechnology Reports Fiscal 2010 Second Quarter Financial Results 2Champions Biotechnology Reports Fiscal 2010 Second Quarter Financial Results 3Champions Biotechnology Reports Fiscal 2010 Second Quarter Financial Results 4Champions Biotechnology Reports Fiscal 2010 Second Quarter Financial Results 5Favorable Vote from FDA Advisory Committee on Benefit/Risk of CRESTOR(R) (rosuvastatin calcium) in JUPITER Study 2Favorable Vote from FDA Advisory Committee on Benefit/Risk of CRESTOR(R) (rosuvastatin calcium) in JUPITER Study 3Favorable Vote from FDA Advisory Committee on Benefit/Risk of CRESTOR(R) (rosuvastatin calcium) in JUPITER Study 4Favorable Vote from FDA Advisory Committee on Benefit/Risk of CRESTOR(R) (rosuvastatin calcium) in JUPITER Study 55 Seniors Win $2,500 Dakim BrainFitness System to Fight Alzheimer's 25 Seniors Win $2,500 Dakim BrainFitness System to Fight Alzheimer's 3Yerkes researchers propose ambitious new strategies for AIDS vaccine research 53971 1Yerkes researchers propose ambitious new strategies for AIDS vaccine research 53971 2Yerkes researchers propose ambitious new strategies for AIDS vaccine research 53971 3The hepatitis healing power of blueberry leaves 9519 1GeoVax Labs Inc Announces Six Month 2009 Financial Results and Provides Operational Update 53964 1GeoVax Labs Inc Announces Six Month 2009 Financial Results and Provides Operational Update 53964 2GeoVax Labs Inc Announces Six Month 2009 Financial Results and Provides Operational Update 53964 3GeoVax Labs Inc Announces Six Month 2009 Financial Results and Provides Operational Update 53964 4GeoVax Labs Inc Announces Six Month 2009 Financial Results and Provides Operational Update 53964 5GeoVax Labs Inc Announces Six Month 2009 Financial Results and Provides Operational Update 53964 6GeoVax Labs Inc Announces Six Month 2009 Financial Results and Provides Operational Update 53964 7
... Up to 24 Hours After,Exposure to Anthrax, ... Targanta,Therapeutics Corporation announced today the results from ... therapy for treating,exposure to Bacillus anthracis, the ... Oritavancin, a novel semi- synthetic,lipoglycopeptide antibiotic for ...
... GTx, Inc., (NASDAQ:,GTXI) announced today that data from ... of Ostarine(TM) and from the ongoing Phase,III clinical ... treatment of multiple side effects of androgen,deprivation therapy ... Meeting of the American Society of Clinical Oncology ...
Other Medicine Technology:Targanta Study Shows Oritavancin Treatment Effective in a Mouse,Model of Anthrax 2Targanta Study Shows Oritavancin Treatment Effective in a Mouse,Model of Anthrax 3Targanta Study Shows Oritavancin Treatment Effective in a Mouse,Model of Anthrax 4GTx Announces Presentation of Ostarine and Acapodene Data at 2007,ASCO Annual Meeting 2GTx Announces Presentation of Ostarine and Acapodene Data at 2007,ASCO Annual Meeting 3
Luria bertani broth: 1.0% Tryptone, 0.5% Yeast Extract, 1.0% Sodium Chloride....
2.5% Soytone, 4.8% Yeast Extract, 0.025% Magnesium Sulfate, 130mM Calcium Chloride....
...
5.0% Casein digest (NZ amine), 2.5% Sodium Chloride, 2.5% Yeast Extract....
Medicine Products: